Inflammation is known to be an essential trigger of the pathological changes that have a critical impact on nerve repair and regeneration; moreover, damage to peripheral nerves can cause a loss of sensory function and produces persistent
neuropathic pain. To date, various potential approaches for
neuropathic pain have focused on controlling
neuroinflammation. The aim of this study was to investigate the
neuroprotective effects of a new association of ultramicronized
Palmitoylethanolamide (PEAum), an
Autacoid Local Injury Antagonist
Amide (ALIAmide) with
analgesic and anti-inflammatory properties, with
Paracetamol, a common
analgesic, in a rat model of sciatic nerve injury (SNI). The association of PEAum-
Paracetamol, in a low dose (5 mg/kg + 30 mg/kg), was given by oral gavage daily for 14 days after SNI. PEAum-
Paracetamol association was able to reduce
hyperalgesia, mast cell activation, c-Fos and
nerve growth factor (
NGF) expression, neural histological damage,
cytokine release, and apoptosis. Furthermore, the
analgesic action of PEAum-
Paracetamol could act in a synergistic manner through the inhibition of the NF-κB pathway, which leads to a decrease of
cyclooxygenase 2-dependent
prostaglandin E2 (COX-2/
PGE2) release. In conclusion, we demonstrated that PEAum associated with
Paracetamol was able to relieve
pain and
neuroinflammation after SNI in a synergistic manner, and this therapeutic approach could be relevant to decrease the demand of
analgesic drugs.